TIOSPIR Trademark

Trademark Overview

On Wednesday, December 11, 2013, a trademark application was filed for TIOSPIR with the United States Patent and Trademark Office. The USPTO has given the TIOSPIR trademark a serial number of 79143369. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Sunday, December 10, 2023. This trademark is owned by Boehringer Ingelheim Pharma GmbH & Co. KG. The TIOSPIR trademark is filed in the Education & Entertainment Services category with the following description:

Publication of printed matter and providing non-downloadable electronic publications with the results of clinical studies involving pharmaceutical preparations
tiospir

General Information

Serial Number79143369
Word MarkTIOSPIR
Filing DateWednesday, December 11, 2013
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateSunday, December 10, 2023
Registration Number4619239
Registration DateTuesday, October 14, 2014
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 29, 2014

Trademark Statements

Goods and ServicesPublication of printed matter and providing non-downloadable electronic publications with the results of clinical studies involving pharmaceutical preparations
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status CodeH - NOT AVAILABLE
Class Status DateSunday, December 10, 2023
Primary Code041
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBoehringer Ingelheim Pharma GmbH & Co. KG
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressIngelheim 55218
DE
Party NameBoehringer Ingelheim Pharma GmbH & Co. KG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
Address55218 Ingelheim
DE
Party NameBoehringer Ingelheim Pharma GmbH & Co. KG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
Address55218 Ingelheim
DE

Trademark Events

Event DateEvent Description
Tuesday, March 11, 2014APPLICATION FILING RECEIPT MAILED
Thursday, March 6, 2014SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, March 7, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 18, 2014NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, May 21, 2014TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 13, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 14, 2014ASSIGNED TO EXAMINER
Monday, March 17, 2014NON-FINAL ACTION WRITTEN
Wednesday, March 19, 2014REFUSAL PROCESSED BY MPU
Wednesday, March 19, 2014NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, April 4, 2014REFUSAL PROCESSED BY IB
Monday, June 2, 2014PAPER RECEIVED
Thursday, June 12, 2014ASSIGNED TO LIE
Friday, June 13, 2014AMENDMENT FROM APPLICANT ENTERED
Thursday, July 24, 2014NOTIFICATION PROCESSED BY IB
Monday, June 16, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 19, 2014LIMITATION OF GOODS RECEIVED FROM IB
Tuesday, June 24, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 24, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 24, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, July 9, 2014NOTICE OF PUBLICATION
Wednesday, July 9, 2014NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, July 9, 2014NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, January 14, 2015FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, July 29, 2014PUBLISHED FOR OPPOSITION
Wednesday, July 30, 2014LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Tuesday, October 14, 2014REGISTERED-PRINCIPAL REGISTER
Friday, March 13, 2015FINAL DISPOSITION PROCESSED
Friday, March 13, 2015FINAL DISPOSITION NOTICE SENT TO IB
Friday, April 3, 2015FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, September 17, 2020TEAS SECTION 71 RECEIVED
Wednesday, December 9, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, January 8, 2021REGISTERED-SEC.71 ACCEPTED
Sunday, July 7, 2024DEATH OF INTERNATIONAL REGISTRATION
Sunday, July 7, 2024NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Saturday, October 14, 2023COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Friday, January 8, 2021NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

Related Keywords

tiospir studies clinical involving pharmaceutical preparations results publications matter printed providing